Sionna Therapeutics, Inc. is a company that filed an Annual Report on Form 10-K for the year ended December 31, 2025. Beyond the auditor consent from Deloitte & Touche LLP, the provided text does not contain sufficient detail to describe the company's specific products, services, or operations.
Q2 FY2026 — expected 2026-08-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0001628280-26-012996 | EDGAR | 97K words |
| 2025-03-20 | 2024-12-31 | 0002036042-25-000005 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001628280-25-049251 | EDGAR | 58K words |
| 2025-08-11 | 2025-06-30 | 0002036042-25-000047 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0002036042-25-000016 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-02 | 0001628280-26-012993 | EDGAR | 2K words |
| 2025-11-05 | 0001628280-25-049246 | EDGAR | — |
| 2025-08-11 | 0002036042-25-000044 | EDGAR | — |
| 2025-06-13 | 0002036042-25-000018 | EDGAR | — |
| 2025-06-04 | 0001193125-25-134462 | EDGAR | — |
| 2025-05-12 | 0002036042-25-000014 | EDGAR | — |
| 2025-03-20 | 0001193125-25-058306 | EDGAR | — |
| 2025-02-10 | 0001193125-25-023570 | EDGAR | — |
16 total filings indexed. 3 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0002036042 |
| Ticker | SION |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.sionnatx.com |
| Listed | 2025-02-07 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report